Pharmacological treatments can have a major impact on the outcome of rheumatic diseases. To achieve the best results, individual treatment regimens comprising analgesic agents, non-steroidal anti-inflammatory drugs and disease-modifying antirheumatic drugs are used. The success of the latter two groups of drugs in controlling symptoms and suppressing disease is tempered by their potential for adverse effects. Careful and continuous monitoring is needed to maximise the benefits and minimise adverse effects.
No takes yet. Share an insight, caveat, or question.
Lehmann et al. (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: